Literature DB >> 15633017

Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Nicole Baumgarth1, James W Tung, Leonore A Herzenberg.   

Abstract

Natural antibodies are produced at tightly regulated levels in the complete absence of external antigenic stimulation. They provide immediate, early and broad protection against pathogens, making them a crucial non-redundant component of the humoral immune system. These antibodies are produced mainly, if not exclusively, by a subset of long-lived, self-replenishing B cells termed B-1 cells. We argue here that the unique developmental pattern of these B-1 cells, which rests on positive selection by self antigens, ensures production of natural antibodies expressing evolutionarily important specificities that are required for the initial defense against invading pathogens. Positive selection for reactivity with self antigens could also result in the production of detrimental anti-self antibodies. However, B-1 cells have evolved a unique response pattern that minimizes the risk of autoimmunity. Although these cells respond rapidly and strongly to host-derived innate signals, such as cytokines, and to pathogen-encoded signals, such as lipopolysaccharide and phosphorylcholine, they respond very poorly to receptor-mediated activation. In addition, they rarely enter germinal centers and undergo affinity maturation. Thus, their potential for producing high-affinity antibodies with harmful anti-self specificity is highly restricted. The positive selection of B-1 cells occurs during the neonatal period, during which the long-lived self-renewing B-1 population is constituted. Many of these cells (B-1a) express CD5, although a smaller subset (B-1b) does not express this surface marker. Importantly, B-1a cells should not be confused with short-lived anergic B-2 cells, which originate in the bone marrow in adults and initiate CD5 expression and programmed cell death following self-antigen recognition. In summary, we argue here that the mechanisms that enable natural antibody production by B-1 cells reflect the humoral immune system, which has evolved in layers whose distinct developmental mechanisms generate complementary repertoires that collectively operate to maximize flexibility in responses to invading pathogens. B-2 cells, present in what may be the most highly evolved layer(s), express a repertoire that is explicitly selected against self recognition and directed towards the generation of high-affinity antibody response to external antigenic stimuli. B-1 cells, whose repertoire is selected by recognition of self antigen, belong to what may be earlier layer(s) and inherently maintain production of evolutionarily important antibody specificities that respond to pathogen-related, rather then antigen-specific signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633017     DOI: 10.1007/s00281-004-0182-2

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  81 in total

1.  B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity.

Authors:  Marian Szczepanik; Moe Akahira-Azuma; Krzysztof Bryniarski; Ryohei F Tsuji; Ivana Kawikova; Wlodzimierz Ptak; Claudia Kiener; Regis A Campos; Philip W Askenase
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

Review 2.  Immunoglobulins did not arise in evolution to fight infection.

Authors:  J Stewart
Journal:  Immunol Today       Date:  1992-10

3.  All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes.

Authors:  H Masmoudi; T Mota-Santos; F Huetz; A Coutinho; P A Cazenave
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

Review 4.  V-gene usage and N-region insertions in B-1a, B-1b and conventional B cells.

Authors:  A B Kantor
Journal:  Semin Immunol       Date:  1996-02       Impact factor: 11.130

5.  CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells.

Authors:  G Bikah; J Carey; J R Ciallella; A Tarakhovsky; S Bondada
Journal:  Science       Date:  1996-12-13       Impact factor: 47.728

6.  Large numbers of cells in normal mice produce antibody components of isologous erythrocytes.

Authors:  A J Cunningham
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

7.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

Review 8.  Characteristics and development of the murine B-1b (Ly-1 B sister) cell population.

Authors:  A M Stall; S Adams; L A Herzenberg; A B Kantor
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

9.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses.

Authors:  M Kopf; F Brombacher; P D Hodgkin; A J Ramsay; E A Milbourne; W J Dai; K S Ovington; C A Behm; G Köhler; I G Young; K I Matthaei
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

10.  Enhancement of mucosal antibody responses to Salmonella typhimurium and the microbial hapten phosphorylcholine in mice with X-linked immunodeficiency by B-cell precursors from the peritoneal cavity.

Authors:  S S Pecquet; C Ehrat; P B Ernst
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

View more
  177 in total

1.  Pivotal advance: peritoneal cavity B-1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD4+ T cells.

Authors:  David Parra; Aja M Rieger; Jun Li; Yong-An Zhang; Louise M Randall; Christopher A Hunter; Daniel R Barreda; J Oriol Sunyer
Journal:  J Leukoc Biol       Date:  2011-11-04       Impact factor: 4.962

2.  B1a lymphocytes in the rectal mucosa of ulcerative colitis patients.

Authors:  Lino Polese; Riccardo Boetto; Giuseppe De Franchis; Imerio Angriman; Andrea Porzionato; Lorenzo Norberto; Giacomo Carlo Sturniolo; Veronica Macchi; Raffaele De Caro; Stefano Merigliano
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

3.  Antigen-specific antibody responses in B-1a and their relationship to natural immunity.

Authors:  Yang Yang; Eliver Eid Bou Ghosn; Leah E Cole; Tetyana V Obukhanych; Patricia Sadate-Ngatchou; Stefanie N Vogel; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-14       Impact factor: 11.205

Review 4.  Natural IgM antibodies against oxidation-specific epitopes.

Authors:  Christoph J Binder
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

5.  Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury.

Authors:  Mauricio E Vargas; Junryo Watanabe; Simar J Singh; William H Robinson; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

Review 6.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 7.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

8.  The immunopathology of liver granulomas in primary biliary cirrhosis.

Authors:  Zhengrui You; Qixia Wang; Zhaolian Bian; Yuan Liu; Xiaofeng Han; Yanshen Peng; Lei Shen; Xiaoyu Chen; Dekai Qiu; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  J Autoimmun       Date:  2012-06-23       Impact factor: 7.094

Review 9.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

10.  Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease.

Authors:  H E Baxendale; M Johnson; R C M Stephens; J Yuste; N Klein; J S Brown; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.